HF Advisory Group’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Other funds holding GSK
HF Advisory Group's GSK Position: Q3 2026 in Review
HF Advisory Group increased its GSK (GSK) stake by 6.7% in Q3 2026, buying an estimated $25.8K and bringing the position to 8,084 shares worth $389K. The position accounts for 0.12% of the portfolio, ranked #142.
HF Advisory Group first reported a position in GSK in Q4 2022 and has held it in 16 quarters since. The position peaked at $424K in Q4 2025. 266 funds tracked by Wall St. Rank hold GSK as of Q3 2026.
- HF Advisory Group held 8,084 shares of GSK worth $389K as of Q3 2026.
- HF Advisory Group bought 506 GSK shares in Q3 2026, an estimated $25.8K.
- GSK made up 0.12% of HF Advisory Group's portfolio in Q3 2026, its #142 holding.
- HF Advisory Group first reported a position in GSK in Q4 2022 and has held it in 16 quarters since.
- HF Advisory Group's GSK position peaked at $424K in Q4 2025.
- 266 funds tracked by Wall St. Rank held GSK as of Q3 2026.
Based on HF Advisory Group's 13F filing for Q3 2026, filed 9 Oct 2026.